Thompson Dean

CIK 1069096 · Executive Chairman · last filed 2024-06-21

Thompson Dean is an Executive Chairman who has filed 8 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for OABIW, was dated Jun 21, 2024. Across all open-market trades the lifetime net is +$240.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $17.3M across reported positions. 26 SEC filings were submitted jointly with David F Burgstahler.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.33M

Companies

4

Total Filings

8

Lifetime Open-Market Net

$240.11M

Filer Profile

Reported Address
65 EAST 55TH STREET, 18TH FLOOR
C/O AVISTA CAPITAL PARTNERS
NEW YORK, NY 10022
State of Incorporation
DE
Related Filers
David F Burgstahler — 26 joint filings, latest 2024-11-19
Avista Acquisition Corp. — 15 joint filings, latest 2021-05-18
Avista Acquisition, LLC — 15 joint filings, latest 2021-05-18
Avista Capital Partners IV GP, L.P. — 9 joint filings, latest 2021-05-18
Avista Capital Partners IV, L.P. — 9 joint filings, latest 2021-05-18
Joshua Alexander Tamaroff — 7 joint filings, latest 2024-07-02
Avista Capital Partners (Offshore) V, L.P. — 6 joint filings, latest 2024-07-02
Avista Capital Partners V, L.P. — 6 joint filings, latest 2024-07-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OABIW Director 15,855,704 $0.37 $5.83M $0 1 2024-06-21
ORGO Director 7,721,298 $1.49 $11.50M $240.11M 3 2021-05-18
Organogenesis Holdings Inc. (AHPAW) Delisted Executive Chairman 15,561,473 $0.69 $10.79M $0 1 2018-12-12
VWR Corp (VWR) Delisted Director $0 1 2014-10-07

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-06-21 OABIW Mixed +140,000 $0 EDGAR
2023-08-30 Notice (144) −879,004 -$87.9K EDGAR
2023-08-24 Notice (144) −767,515 -$105.8K EDGAR
2021-05-18 ORGO Other (J) −169,236,208 $0 EDGAR
2020-11-24 ORGO Buy (P) +22,712 $113.4K EDGAR
2019-11-27 ORGO Buy (P) +48,000,000 $240.00M EDGAR
2018-12-12 Organogenesis Holdings Inc. (AHPAW) Delisted Mixed +31,122,946 $0 EDGAR
2014-10-07 VWR Corp (VWR) Delisted Grant (A) $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.